Goblet cell autoantibodies in patients with inflammatory bowel disease and their first-degree relatives
Goblet cell autoantibodies in patients with inflammatory bowel disease and their first-degree relatives
复制标题
DOI:
10.1016/s0016-5085(97)70085-4
复制
发表时间:
1997-07-01
期刊:
影响因子:
29.4
通讯作者:
Fricke, H
中科院分区:
文献类型:
--
作者:
Folwaczny, C;Noehl, N;Fricke, H
Background & Aims: Crohn's disease and ulcerative colitis show a familial aggregation. In both diseases, anti-goblet cell autoantibodies (GABs) have been described. The aim of this study was to define the role of GABs in the pathogenesis of inflammatory bowel disease. Methods: The study population comprised 61 patients with ulcerative colitis, 76 patients with Crohn's disease, 101 first-degree relatives of patients with ulcerative colitis, and 105 first-degree relatives of patients with Crohn's disease. Thirty-five patients with infectious enterocolitis and 56 healthy unrelated subjects sewed as controls. Autoantibodies were detected by indirect immunofluorescence. Results: Thirty-nine percent of patients with ulcerative colitis (24 of 61) and 30% of patients with Crohn's disease (23 of 76) were positive for GABs. GABs were detected in 21% (21 of 101) of first-degree relatives of patients with ulcerative colitis and in 19% (20 of 105) of first-degree relatives of patients with Crohn's disease, In patients with infectious enterocolitis and in healthy controls, GABs were seen in 3% (1 of 35) and 2% (1 of 56), respectively. The differences between control groups and both groups of patients or their first-degree relatives were significant. Conclusions: The high prevalence in first-degree relatives suggests that GABs may represent a marker characterizing susceptibility to inflammatory bowel disease.